Quantum chemistry calculations for metabolomics: Focus review
A primary goal of metabolomics studies is to fully characterize the small-molecule
composition of complex biological and environmental samples. However, despite advances …
composition of complex biological and environmental samples. However, despite advances …
Elucidating solution structures of cyclic peptides using molecular dynamics simulations
Protein–protein interactions are vital to biological processes, but the shape and size of their
interfaces make them hard to target using small molecules. Cyclic peptides have shown …
interfaces make them hard to target using small molecules. Cyclic peptides have shown …
Conformational Control of Macrocycles by Remote Structural Modification: Focus Review
SD Appavoo, S Huh, DB Diaz, AK Yudin - Chemical reviews, 2019 - ACS Publications
The conformational analysis of macrocycles is a complex and challenging problem. There
are many factors that contribute to this complexity. These include a large number of degrees …
are many factors that contribute to this complexity. These include a large number of degrees …
[HTML][HTML] Applications of molecular dynamics simulation in structure prediction of peptides and proteins
H Geng, F Chen, J Ye, F Jiang - Computational and structural …, 2019 - Elsevier
Compared with rapid accumulation of protein sequences from high-throughput DNA
sequencing, obtaining experimental 3D structures of proteins is still much more difficult …
sequencing, obtaining experimental 3D structures of proteins is still much more difficult …
Going Out on a Limb: Delineating The Effects of β-Branching, N-Methylation, and Side Chain Size on the Passive Permeability, Solubility, and Flexibility of …
AT Bockus, JA Schwochert, CR Pye… - Journal of Medicinal …, 2015 - ACS Publications
It is well established that intramolecular hydrogen bonding and N-methylation play important
roles in the passive permeability of cyclic peptides, but other structural features have been …
roles in the passive permeability of cyclic peptides, but other structural features have been …
Cyclosporin A: conformational complexity and chameleonicity
S Ono, MR Naylor, CE Townsend… - Journal of chemical …, 2021 - ACS Publications
The chameleonic behavior of cyclosporin A (CsA) was investigated through conformational
ensembles employing multicanonical molecular dynamics simulations that could sample the …
ensembles employing multicanonical molecular dynamics simulations that could sample the …
Cyclization and docking protocol for cyclic peptide–protein modeling using HADDOCK2. 4
V Charitou, SC Van Keulen… - Journal of chemical …, 2022 - ACS Publications
An emerging class of therapeutic molecules are cyclic peptides with over 40 cyclic peptide
drugs currently in clinical use. Their mode of action is, however, not fully understood …
drugs currently in clinical use. Their mode of action is, however, not fully understood …
Conformation and permeability: cyclic hexapeptide diastereomers
S Ono, MR Naylor, CE Townsend… - Journal of chemical …, 2019 - ACS Publications
Conformational ensembles of eight cyclic hexapeptide diastereomers in explicit
cyclohexane, chloroform, and water were analyzed by multicanonical molecular dynamics …
cyclohexane, chloroform, and water were analyzed by multicanonical molecular dynamics …
Analysis of loops that mediate protein–protein interactions and translation into submicromolar inhibitors
TR Siegert, MJ Bird, KM Makwana… - Journal of the American …, 2016 - ACS Publications
Effective strategies for mimicking α-helix and β-strand epitopes have been developed,
producing valuable inhibitors for some classes of protein–protein interactions (PPIs) …
producing valuable inhibitors for some classes of protein–protein interactions (PPIs) …
Docking Flexible Cyclic Peptides with AutoDock CrankPep
While a new therapeutic cyclic peptide is approved nearly every year, docking large
macrocycles has remained challenging. Here, we present a new version of our peptide …
macrocycles has remained challenging. Here, we present a new version of our peptide …